Medical Polytetrafluoroethylene (PTFE) Market Size, Share & Trends | Industry Report, 2018-2026
Rising
adoption of PTFE in implantable prosthetic heart valve rings is expected to
stimulate the market demand.
Market
Size – USD 374.62 Million in 2018, Market Growth - CAGR of 3.8%, Market Trends
–The use of PTFE in guided tissue regeneration process is a major factor for
the growth in PTFE membrane market.
The
global Medical
Polytetrafluoroethylene Market is expected to reach USD 504.24
million by 2026, according to a new report by Reports and Data. There has been
an impressive growth of fluoropolymers in the medical industry. Fluoropolymers
such as PTFE are replacing plastics, metals, and ceramics used in clinical
applications. A clinical report name ‘Biomaterials for periodontal
regeneration’ reveals that e-PTFE is being widely used as an alternative to
membrane positions made up of calcium sulfate in periodontal operations.
PTFE
has witnessed an increased adoption in the medical industry mainly in the
dental sector. In dental implants, the PTFE membrane acts as an obstruction and
prevents the gums from growing inside the bone cavity. Dense PTFE membranes are
used for preparing dental implants in post-extraction bone regeneration.
According to the American Society for Prosthodontics, approximately 52 % of the
U.S. adults suffer from some form of periodontal disorders, and around 190
million adults by 2025 in the U.S. will be facing a partial tooth loss problem.
Increasing incidence of dental injuries is likely to increase the application
of PTFE membrane barriers by dental surgeons.
Request
for PDF Sample at: https://www.reportsanddata.com/sample-enquiry-form/1213
Europe
is projected to grow significantly in the forecasted period. The market is
expected to grow at a CAGR of 3.4% in the coming years. In the European region,
PTFE is being increasingly adopted in the medical sector. The increasing
prevalence of periodontics is likely to drive demand for guided tissue
regeneration for dental regeneration therapy. Based on 2013 statistics, over 50
percent of the European population suffers from some form of periodontitis, and
over 10 percent have severe disease with prevalence increasing to 70-85 percent
of the population aged 60-65 years of age.
Further
key findings from the report suggest
- The rise in the occurrence of periodontal
diseases is expected to boost the medical PTFE market. Based on a report
by the Centers for Disease Control and Prevention, 47.2 of adults aged 30
years and older in the U.S. have some form of periodontal disease.
Moreover, the incidence of periodontal disease is higher in men than women
(56.4 vs. 38.4 respectively).
- The European market is forecasted to grow at a
CAGR of 3.4% in the coming years. According to WHO, about 20% of the middle-aged
population and about 40% of the older aged population has severe
periodontal disease in Europe. Even though there is a vast population of
people suffering from dental problems, it is not acknowledged much in
Europe. Additionally, based on a report, the incidence of abdominal aortic
aneurysm (AAA) in England and Wales has been increasing. The incidence of
an AAA was 7.6 percent in men and 4.2 percent for women in 2013.
- Saint Gobain, W.L.Gore & Associates Inc,
Donaldson Company, Sumitomo Electric, Pall Corporation, Markel, Zeus Inc.,
Chukoh Chemical Industries Ltd. Donaldson Company is a crucial player in
the Medical Polytetrafluoroethylene market. With a global presence in the
U.S., Europe, and the Asia Pacific, the company offers a wide range of PTFE
filter applications under Tetratex PTFE membrane. As of 2017, the
company’s net earnings accounted for USD 232.8 million.
Read
more at: https://www.reportsanddata.com/report-detail/medical-polytetrafluoroethylene-ptfe-market
For
the purpose of this report, Reports and Data have segmented global Medical
Polytetrafluoroethylene on the basis of material, vehicle type, application,
and region:
Form
Type (Revenue, USD Million; 2016-2026)
- Pastes
- Tubes
- Sheets
- Fabric
Application
Type (Revenue, USD Million; 2016-2026)
- Grafts
- Sutures
- Dental
- Pharmaceutical
- Others
Regional
Outlook (Revenue, USD Billion, 2018-2026)
- North America
1. U.S.
- Europe
1. Germany
2. UK
- Asia Pacific
1. China
2. India
- Latin America
1. Brazil
- MEA
Comments
Post a Comment